Transfusion Medicine

Papers
(The median citation count of Transfusion Medicine is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Reactions to serum eye drops—New Zealand experience and review of the literature16
Apparent changes in RhD status during pregnancy: A case study of weak D variant due to RHD*DAU‐215
The impact of pathogen‐reduced platelets in acute leukaemia treatment on the total blood product requirement: a subgroup analysis of an EFFIPAP randomised trial14
Understanding hepcidin for iron management in pregnancy14
The influence of the COVID‐19 pandemic on blood donation and supply in China12
Sickle cell disease patients in two London trusts: Genotyping including RH variants10
A Houdini act: Transient loss of Jka resulting in anti‐Jk3 antibody formation10
High B‐cell activating factor levels in multi‐transfused thalassemia patients9
Congress report: Online workshop on assessment of technical files for blood screening in vitro diagnostics for sub‐Sahara African countries9
On consciousness of the decision to discontinue blood donation: Intention to return and effective recovery activities9
9
Re‐examine the transfusion transmitted risk of SARS‐CoV‐2 virus during a major COVID‐19 outbreak in 20228
8
2021: That was the year that was8
Fresh frozen plasma: Beyond coagulation factor content7
Issue Information7
Validation of the Sysmex XN analyser and Blood Bank mode for the quality and safety of donor blood and transfusion products7
Platelets inhibit erythrocyte invasion by Plasmodium falciparum at physiological platelet:erythrocyte ratios7
Chikungunya virus seroprevalence in asymptomatic blood donors during an outbreak in the Federal District of Brazil7
Diagnostic accuracy of Abbott Architect Assay as a screening tool for human T‐cell leukaemia virus type‐1 and type‐2 infection in a London teaching hospital with a large solid organ transplant centre7
Issue Information7
Issue Information7
Evidence cornered: Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT trial)6
The CRYOSTAT2 trial: The rationale and study protocol for a multi‐Centre, randomised, controlled trial evaluating the effects of early high‐dose cryoprecipitate in adult patients with major6
A nait‐associated and previously unreported mutation in the ITGB3 gene with a low frequency in the local population6
Author Index6
Improvement of platelet preservation by inhibition ofTRPC65
Issue Information5
Iron deficiency in whole blood donors in a resource‐poor setting: A cross‐sectional study in Uganda5
5
Low‐titer group O whole blood in military ground ambulances: Lessons from the Israel Defense Forces initial experience5
Deterrents in recruitment of COVID‐19 convalescent plasma donors: Experience from a hospital‐based blood centre in India5
Frequency of red blood cell phenotypes from genotyped Australian blood donors5
Stability of immunohaematological reagents used for blood typing of recipients in the tube technique5
Comparison of European recommendations about patient blood management in postpartum haemorrhage5
Evidence Cornered: Transfusion Evidence Summary – Platelet transfusion before CVC placement in patients with thrombocytopenia (PACER trial)4
Implementation challenges of electronic blood transfusion safety systems: Lessons from an international, multi‐site comparative case study4
Efficacy and safety of BT595 (10% human intravenous immunoglobulin) in adult patients with chronic immune thrombocytopenia4
Evidence cornered: Transfusion evidence summary—efficacy and safety of early administration of 4‐factor prothrombin complex concentrate in patients with trauma at risk of massive transfusio4
Surgical patients' perception about risks related to blood transfusion: A cross‐sectional survey4
Intravenous immunoglobulin alteration in response to adverse reactions in neurological conditions: A retrospective cohort study4
An accurate genetic assay to identify human neutrophil antigen 2 deficiency4
4
A review of immunoglobulin use in a district general hospital setting3
Validation of pathogen reduced plasmas from maxi‐pools combined with fast thawing3
Suggested blood donor deferral strategy regarding hepatitis B infections in China3
Recovery of platelet‐rich red blood cells and acquisition of convalescent plasma with a novel gravity‐driven blood separation device3
Role of disruptions in O RhD negative donations in Colombia on increasing maternal mortality ratio from haemorrhage3
Individual and environmental determinants of serum ferritin levels: A structural equation model3
Charles Waller and Edward Doubleday—Colleagues of James Blundell and early supporters of blood transfusion3
Virological safety of the UK blood supply in the era of individual risk assessments and HIV PrEP3
BGvar: A comprehensive resource for blood group immunogenetics3
Plenary I3
Exploring the increasing need for plasma collection: Perspectives of voluntary nonremunerated donors on payment for plasma in Canada3
Using trends and outliers in managing delayed transfusions3
The infected blood inquiry: Impact on public perceptions of blood supply risk, safety, and donation attitudes3
Higher levels of von Willebrand factor in hospitalised patient plasma provides an explanation for the association of ABO blood group and secretor status with COVID19 severity3
Genetic profile of RHCE, Kell, Duffy, Kidd, Diego and MNS hybrid glycophorins blood groups in ethnic northeastern Thais: Alleles, genotypes and risk of alloimmunisation3
HLA‐DRB1 and cytokine polymorphisms in Brazilian patients with myelodysplastic syndromes and its association with red blood cell alloimmunization3
Author Index3
Transfusion sample mislabelling and wrong blood in tube in the UK: Insights from the national comparative audits of blood transfusion in 2012 and 20223
Drivers of blood use in paediatric trauma: A retrospective cohort study2
An evaluation of diethylhexyl phthalate free top & bottom in‐line blood collection set with a new soft housing filter2
Assessing motivations for non‐living and living organ donation among individuals with and without a history of blood donation2
Perioperative transfusion study (PETS): Does a liberal transfusion protocol improve outcome in high‐risk cardiovascular patients undergoing non‐cardiac surgery? A randomised controlled pilo2
2
Preventing antibody positive delayed hemolytic transfusion reactions in sickle cell disease: Lessons learned from a case2
The ongoing dilemma of prophylactic platelet transfusions pre‐procedure and the development of evidence‐based recommendations2
Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approach2
Corrigendum2
Issue Information2
Reflection from managing blood supply during social unrest2
Red blood cell alloimmunisation in sickle cell disease patients in the Democratic Republic of the Congo2
Identification of a novel RHCE*Ce (829G > A) allele associated with absence of C and e antigens expression2
Patterns of paediatric massive blood transfusion protocol use in trauma and non‐trauma patients2
Transfusion 2024: A 5‐year plan for clinical and laboratory transfusion in England2
Severe acute haemolytic transfusion reaction secondary to a plasma incompatible group B platelet transfusion2
Molecular validation of pathogen‐reduction technologies using rolling‐circle amplification coupled with real‐time PCR for torquetenovirus DNA quantification2
Effect of convalescent plasma as complementary treatment in patients with moderate COVID‐19 infection2
Wednesday 18 September 2024 Simultaneous sessions2
Blood transfusion demands in a tertiary otolaryngology, head and neck centre: A 5‐year retrospective cohort study2
Assessment the knowledge of blood transfusion in Iranian nurses of Tehran's hospitals2
2
Wednesday 11 October 2023 Simultaneous Sessions2
Hepatitis C virus screening reactive among blood donors in mainland China: A systematic review and meta‐analysis2
Pain control and functional improvement in patients treated by autologous conditioned serum after failure of platelet rich plasma treatments in knee osteoarthritis2
Confirmed non‐invasive prenatal testing for foetal Rh blood group genotyping along with bi‐allelic short insertion/deletion polymorphisms as a positive internal control2
Factors influencing white blood cell mobilisation in healthy granulocyte donors2
Prevalence of leucocyte antibodies in non‐transfused male and female platelet apheresis donors1
Blood loss and transfusion risk in intramedullary nailing for subtrochanteric fractures1
Poster session1
1
Blood transfusion in the Caribbean: Historical perspective in the context of Trinidad and Tobago1
Safe handovers: Safe patients‐why good quality structured handovers in the transfusion laboratory are important1
A multidisciplinary comparison of transfusion and perioperative support for high‐risk cardiac surgery at three large academic centres in North America1
1
Optimizing blood utilization: Experience of blood redistribution policy from a tertiary care hospital based blood centre1
Rhnull phenotype in an Indian patient due to a novel c.1138 + 2 t > a mutation in the RHAG gene1
Plasma exchange in acute hemolytic reaction due to ABO‐incompatible erythrocyte concentrate transfusions: Single center experience1
Preliminary study on the function of TMEM50A and its correlation with the RH genes1
The feasibility of introducing a whole blood component for traumatic haemorrhage in the UK1
COP27 Climate Change Conference: Urgent action needed for Africa and the world1
Monitoring iron stores in Icelandic blood donors from 1997 through 20191
Bone marrow changes in a fatal case of transfusion associated—Graft versus host disease1
Resuscitation of adult shocked trauma patients using major haemorrhage protocol guided by viscoelastic haemostatic assays versus formulaic approach1
Evaluation of two temperature storage conditions for full blood count samples from Lifeblood's donors1
Transfusing selected RhD negative patients with RhD positive packed red cell concentrates resulted in lower frequency of anti‐D development and saved almost two thousand RhD1
Issue Information1
1
Hemolysis during therapeutic plasma exchange: A rare phenomena1
Optimising platelet usage during the induction therapy of acute myeloid leukaemia: Impact of physician education1
‘Old is gold’ does conventional test tube method still reign supreme? An immuno‐haematological survey of anti‐D detection and titration in ante‐natal cases among major hospitals across India1
Utility of pre‐operative haemoglobin concentration to guide peri‐operative blood tests for hip and knee arthroplasty: A decision curve analysis1
Acute normovolemic haemodilution to reduce allogeneic red blood cell transfusion in patients undergoing coronary artery bypass grafting. An observational study1
Comparative analysis of hepatitis B virus infections in blood donors born before and after the implementation of universal HBV vaccination in southern China1
Issue Information1
Issue Information1
Reviewer Acknowledgement 20211
Issue Information1
Amber coloured plasma—Case for illustration1
Prevalence and incidence of transfusion‐transmissible infections among blood donors in Malawi: A population‐level study1
Oral sessions1
Evaluation of platelet concentrates prepared using different methods after overnight holding (18–24 h) of whole blood at room temperature1
Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield/window period model in an Indian setting1
A possible dose‐response equation: Viral load after plasma infusion in COVID‐19 patients and anti‐SARS‐CoV‐2 antibody titers in convalescent plasma1
D‐‐phenotype due to RHD‐RHCE hybrid transcript in a case of severe haemolytic disease of newborn with anti‐Rh 17(Hrₒ) antibodies1
Machine learning for predicting preoperative red blood cell demand1
Reflections of a re‐engaged donor. A response to ‘on consciousness of the decision to discontinue blood donation: Intention to return and effective recovery activities’1
Corrigendum1
Issue Information1
Reviewer Acknowledgement 20221
Serological screening and genetic analysis ofRhCEvariants in the Chinese Southern Han donors1
BNT162b2 mRNA vaccine in transfusion dependent thalassemia patients1
Development and validation of a nomogram to predict intraoperative blood transfusion for gastric cancer surgery1
Prevalence, incidence, risk factors and residual risk associated with viral infections among eligible Brazilian blood donors1
Viral safety of recovered plasma for contract fractionation; an Iranian experience, 2006–20151
Salvage of refractory post‐transfusion hyperhaemolysis by targeting hyperinflammation and macrophage activation with tocilizumab1
Issue Information1
1
Discrepancies among studies reporting the prevalence of positive direct antiglobulin tests in the COVID‐19 patient population1
Use of automated haematology analysers for the quality control of blood components for transfusion: Comment on Valina et al. (Transfusion Medicine 2024;34:30–38)1
Every minute counts: A comparison of thawing times and haemostatic quality of plasma thawed at 37°C and 45°C using four different methods1
Issue Information1
Notes from the Basho of the blood service1
Anti‐AnWj antibody induced haemolytic transfusion reaction in a patient with primary acquired pure red cell aplasia1
1
Issue Information1
Risk of transfusion‐associated malaria in sub‐Saharan Africa: The case of Mali1
Cold agglutinin syndrome in a patient with anaemia and beta‐thalassemia trait1
Validation of current commercially‐available devices to thaw pooled, solvent/detergent‐treated human plasma1
Wednesday 14 September 2022 Simultaneous Session1
Plenary session I1
The importance of need‐altruism and kin‐altruism to blood donor behaviour for black and white people1
SARS‐CoV‐2 infection in the blood transfusion setting1
Impact of microbial contamination of haematopoietic stem cells on post‐transplant outcomes: A retrospective study from tertiary care centre in India0
Sample collection for pre‐transfusion crossmatching: Benefits of using an electronic identification system0
Designing and testing an ethnic‐ancestry question for Australian blood donors: Acceptability, feasibility, and understanding0
Tuesday 10 October 2023 Sig Session0
Utility of rotational thromboelastometry in the management of massive haemorrhage at a regional Australian hospital0
Probable cefepime‐induced immune mediated hemolytic anaemia0
Rh(D) immune globulin administration in pregnancy: Retrospective audit of patient safety events followed by targeted educational intervention with Bayesian analysis0
Prophylactic tranexamic acid use in non‐cardiac surgeries at high risk for transfusion0
A second look at the mortality in thrombotic thrombocytopenic purpura score: An external validation study0
Blood transfusion in injured older adults: A retrospective cohort study0
Issue Information0
Oral Abstracts0
Successful haematopoietic progenitor cell collection by plerixafor in combination with reduced dose granulocyte colony‐stimulating factor for severe hypoxemia provoked by high‐dose granulocyte colony‐0
Acute pancreatitis from a delayed haemolytic transfusion reaction0
Blood transfusion needs in COVID‐19 patients: An observational prospective unicentric study0
Issue Information0
0
Extracellular vesicles in ageing cold‐stored whole blood may not compensate for the decreasing haemostatic function in vitro0
A prospective, multi‐centric study on the prevalence of dengue, zika and chikungunya in asymptomatic blood donors from different geographical regions of Brazil0
A physiology‐based trigger score to guide perioperative transfusion of allogeneic red blood cells: A multicentre randomised controlled trial0
Passenger lymphocyte syndrome with severe haemolysis misdiagnosed/treated as cold agglutinin syndrome: Analysis of case and diagnostic error0
Preventing misinterpretation of rare blood types in clinical laboratories: A case study on B3 phenotype0
Evaluating the risk of transfusion and transplant‐transmitted monkeypox infections0
Transfusion Camp: The UK experience and its value in improving knowledge of transfusion medicine among postgraduate trainees0
A systematic review of the safety and efficacy of convalescent plasma or immunoglobulin treatment for people with severe respiratory viral infections due to coronaviruses or influenza0
Systematic review and meta‐analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 (COVID‐19): Evidence‐0
Issue Information0
Evaluation of Dengue, Zika virus, and Chikungunya virus transmission by blood components in recipients of haematopoietic stem cell transplantation0
Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England0
0
Prevention strategies for vasovagal reaction in whole blood donors: A quadri‐armed randomised control trial0
Prevalence of red blood cell alloantibodies in pregnant women with sickle cell disease in Bamako0
Randomised controlled trial of glucose‐6‐phosphate dehydrogenase deficient versus non‐deficient red blood cell transfusion in patients with hypoproliferative anaemia0
Introduction of EUBIS standards to upgrade inspections of blood establishments to improve the safety of blood transfusion: The Polish experience0
Issue Information0
Tuesday 17 September 2024 SIG session0
Poster Presentations0
Validation of an apoptosis assay for extracorporeal photopheresis0
Issue Information0
Author Index0
Issue Information0
A novel homozygous splice‐site mutation of JK gene leads to Jk(a‐b‐) phenotype0
Issue Information0
The Norwegian experience with nationwide implementation of fetal RHD genotyping and targeted routine antenatal anti‐D prophylaxis0
A difficult year… so keep on keeping on0
Role of ABO blood system in COVID‐19: Findings from a southern Italian study0
Trust and distrust: Identifying recruitment targets for ethnic minority blood donors0
Comparison of conventional coagulation tests and ROTEM in identifying trauma‐induced coagulopathy for massive haemorrhage protocol activation0
Leukocytapheresis in the management of adults with acute myeloid leukaemia: A survey of AML treating centres highlighting variability in practice0
Recurrent pregnancy loss in a patient with anti‐Rh170
Characterising practice patterns of human derived, lyophilized coagulation concentrates within the trauma quality improvement program registry0
Analysis of a 5‐year, evidenced‐based, rational blood utilisation project in a South African regional hospital0
Corrigendum0
0
Beyond COVID‐19 and lessons learned in the United States0
Convalescent plasma and COVID‐19: Time for a second—second look?0
The use of predictive modelling to determine the likelihood of donor return during the COVID‐19 pandemic0
0
Genetic variation of FUT3 gene in the Han population from Northern China0
0
Importation of plasma and use of apheresis platelets as risk reduction measures for variant Creutzfeldt‐Jakob disease: The SaBTO review0
Allogenic and autologous nondiluted serum eye drops—validation strategy compliant with good manufacturing practice0
UK national survey of anticoagulation in extra‐corporeal photopheresis—Is it time for a UK consensus statement?0
Establishment and discussion of autoverification rules for transfusion compatibility testing0
How do we translate gaps and unmet needs of blood management for thalassemia into a collaborative implementation framework?0
Prevalence and specificity of red blood cell antibodies in patients transfused in tertiary hospitals in Burkina Faso0
Plenary III0
Comparing transfusion practice at multiple hospitals using electronically collected and analysed data0
Effects of cryopreservation on gram‐positive bacteria contaminants in umbilical cord blood0
Issue Information0
Poster Presentations0
The use of prothrombin complex concentrate in chronic liver disease: A review of the literature0
0
0
Impact of the COVID‐19 outbreak on blood supply in two large university hospitals0
Evaluating utility of routine ferritin testing in blood donors: A hospital‐based blood donor centre experience0
Construction of a decision model for donor testing in cases of suspected antibody‐mediated transfusion‐related‐acute‐lung‐injury0
Issue Information0
Risk factors for red blood cell alloimmunization in patients with hematologic malignancy0
E‐learning/online education in transfusion medicine: A cross‐sectional international survey0
Alloanti‐Hy in antenatal patients: A multi‐case review0
Hyperhaemolysis caused by anti‐HI antibodies in a patient with myelodysplastic syndrome following a first ever red cell transfusion0
Systematic review of prevalence and risk factors of transfusion transmissible infections among blood donors, and blood safety improvements in Southern Africa0
0
Investigating non‐immune haemolytic transfusion reactions in surgical patients0
Thursday 15th September 2022 Simultaneous sessions0
Issue Information0
Chikungunya and Mayaro infective viruses in components of blood0
Red blood cell transfusion in myelodysplastic syndromes: A systematic review0
Time to be proactive about passive D: Distinguishing anti‐D alloimmunisation from RhIG0
Does decreasing the incubation period used in the antibody screen affect its sensitivity?0
A challenge for blood management: A patient presenting anti‐Vel antibody undergoing orthotopic liver transplantation0
0
Risk of hepatitis‐E virus infections among blood donors in a regional blood transfusion centre in western India0
0
HLA class I and HPA9b related fetal‐neonatal alloimmune thrombocytopenia0
0.063858032226562